RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

81 hedge funds and large institutions have $816M invested in Ultragenyx Pharmaceutical in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+4
Holders Change %
+5.19%
% of All Funds
2.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
31
Reduced
26
Closed
9
Calls
$293K
Puts
$251K
Net Calls
+$42K
Net Calls Change
+$42K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$125M
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$10.4M
3
Citadel Advisors
3
Citadel Advisors
Florida
$9.27M
4
CI
4
Cowen Inc
New York
$6.3M
5
Goldman Sachs
5
Goldman Sachs
New York
$8.52M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$53.7M
2
TCP
2
Tourbillon Capital Partners
New York
$0
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$78.9M
4
Jennison Associates
4
Jennison Associates
New York
$9.79M
5
Millennium Management
5
Millennium Management
New York
$644K
Name Holding Trade Value Shares
Change 		Shares
Change %
DCM
26
Driehaus Capital Management
Illinois
$4.12M +$1.34M +29,921 +48%
State Street
27
State Street
Massachusetts
$4.12M +$1.25M +27,889 +44%
Northern Trust
28
Northern Trust
Illinois
$3.9M +$2.6M +57,872 +200%
BIT
29
BlackRock Institutional Trust
California
$3.6M -$1.13M -25,136 -24%
WMSA
30
Weiss Multi-Strategy Advisers
New York
$3.56M +$173K +3,850 +5%
RSCM
31
Rock Springs Capital Management
Maryland
$2.94M +$628K +14,000 +27%
PI
32
Putnam Investments
Massachusetts
$2.91M – – –
EAM
33
Eventide Asset Management
Massachusetts
$2.36M +$2.36M +52,600 New
TG
34
TCW Group
California
$2.33M +$1.24M +27,720 +115%
BIM
35
BlackRock Investment Management
Delaware
$2.05M +$1.19M +26,546 +140%
OM
36
Opaleye Management
Massachusetts
$2.02M +$2.02M +45,000 New
Morgan Stanley
37
Morgan Stanley
New York
$1.98M -$1.7M -37,951 -46%
IHM
38
Iguana Healthcare Management
New York
$1.88M -$592K -13,200 -24%
EA
39
Emerald Advisers
Pennsylvania
$1.74M +$541K +12,040 +45%
Geode Capital Management
40
Geode Capital Management
Massachusetts
$1.65M +$34.9K +778 +2%
EMFAT
41
Emerald Mutual Fund Advisers Trust
Pennsylvania
$1.56M +$548K +12,204 +54%
JHIU
42
Janus Henderson Investors US
Colorado
$1.45M -$1.26M -28,135 -47%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$1.35M +$475K +10,571 +55%
BA
44
BlackRock Advisors
Delaware
$1.2M -$2.85M -63,584 -70%
RFS
45
Rockefeller Financial Services
New York
$1.17M +$645K +14,380 +123%
TCIM
46
TIAA CREF Investment Management
New York
$1.15M +$67.6K +1,505 +6%
PAM
47
Panagora Asset Management
Massachusetts
$1.15M -$62.4K -1,389 -5%
Axa
48
Axa
France
$936K – – –
Brown Advisory
49
Brown Advisory
Maryland
$896K -$718 -16 -0.1%
NFA
50
Nationwide Fund Advisors
Ohio
$788K +$333K +7,422 +73%
1
2
3 4